SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.91+1.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (201)7/19/1997 6:33:00 PM
From: Douglas   of 455
 
James, thanks. I won't ask you to go into any more details. I've been researching numerous companies associated with Paramount Capital. Some have lost, others are winners. Zonagen (ZONA) has shown strong price movement on the positive side. Paramount Capital helped obtain a private placement for this company.

I noticed today that a recent investor in Procept, Mr. Michael Jesselson has made a significant investment in Genta. The 17 July 97 filing of the Schedule 13d for Genta mentions:

Assuming the exercise of all Preferred Stock and Warrants held by the
Trusts, the Reporting Persons may be deemed to beneficially own in the aggregate 1,113,829 shares of Common Stock, representing approximately 20.28% of the Common Stock outstanding.

I hope the stock price goes up and you make some money. I'm tired of the rich getting richer!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext